Bryxta 400mg Injection

Product Description

Bryxta 400mg Injection is an anticancer medication containing the active ingredient Bevacizumab. It is designed to inhibit tumor growth and is prescribed in combination with other chemotherapy drugs to treat various cancers, including:

• Metastatic breast cancer

• Brain cancer

• Cervical cancer

• Kidney cancer

• Lung cancer

• Colorectal cancer

• Ovarian cancer

• Fallopian tube cancer

• Primary peritoneal cancer

Important Considerations:

• Birth Control: Use effective contraception during treatment and for at least six months after the last dose.

• Pregnancy Planning: If you plan to conceive in the future, discuss ovary preservation with your doctor, as this medicine may affect fertility in women.

• Breastfeeding: Avoid breastfeeding during treatment, as the drug may interfere with your baby's growth and development.

• Age Restriction: Not recommended for adolescents and children under 18 years.

Administration and Side Effects:

Bryxta 400mg Injection is typically used in combination with other chemotherapy agents. Common side effects may include:

• Constipation

• Appetite loss

• Runny nose

• Fever

• Skin problems

• Weight loss

Precautions:

Before starting treatment, inform your doctor if you have:

• High blood pressure

• High blood sugar

• Stomach disorders

• Heart problems

Additionally, avoid this medication for 28 days before and after surgery due to the risk of poor wound healing and excessive bleeding. If you have dental issues requiring surgery, consult your doctor before starting treatment.

When to Seek Medical Attention:

If you experience any visual disturbances or confusion, contact your doctor immediately to prevent complications.